Tuesday 30 June 2020
Sunday 28 June 2020
India Microfluidics Market to Witness Robust Growth until 2025 – TechSci Research
Launch of microfluidics-based 3D cell culture systems to drive India microfluidics market
According to TechSci Research report, “India Microfluidics Market By Component Type (Microfluidic Chips, Microfluidic Sensors, Microfluidic Pumps, Microneedles, Others), By Material (Polymer, Glass, Silicon, PDMS, Other), By Application (In Vitro diagnostics (Point-of-Care Testing, Clinical Diagnostics, Environmental Testing, Industrial Testing, Agro Food Testing), Pharmaceutical Research (Lab Analytics, Microdispensing, Microreaction), Drug Delivery (Inhaler Nozzles, Microneedles, Micropumps), By Region, Forecast & Opportunities, 2025”, the market is anticipated to witness robust growth during the forecast period owing to technological advancements in healthcare sector including development of advanced lab-on-a-chip technologies. The market is also witnessing surging demand for point-of-care testing and in-vitro diagnostics, which are acting as key growth drivers for India microfluidics market. Moreover, development of advanced lab-on-a-chip technologies and high-throughput screening methodologies are key growth drivers for the market. Additionally, with growing focus on data precision & accuracy, the market is expected to grow further over the coming years.
Additionally, the advantages offered by microfluidics including fast returns on investment and rapid testing are fueling the growth of this market in India. Launch of microfluidics-based 3D cell culture systems like organ-on-a-chip has led to spike in demand for microfluidics in the country. Also, growing application of drug delivery technologies is acting as major growth factor for India microfluidics market.
However, the market might also face some restrains. Stringent regulatory framework for approval of microfluidics devices might pose as a challenge before manufacturers. Moreover, high price of integrated systems and microfluidics sensors might limit the market growth in India.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on "India Microfluidics Market"
The India microfluidics market is segmented based on component type, material, application, sector, end user and region. Based on application, the market is segmented into in vitro diagnostics, pharmaceutical research and drug delivery. The in vitro diagnostics segment is further split into point-of-care testing, clinical diagnostics, environmental testing, industrial testing and agro food testing. Moreover, the pharmaceutical research segment is categorized into lab analytics, microdispensing, microreaction and drug delivery segment is categorized into inhaler nozzles, microneedles and micropumps. Among them, the in vitro diagnostics segment is expected to witness highest growth in India through 2025 owing to high demand for point-of-care testing and increasing adoption of microfluidic techniques in laboratory analytical testing.
Based on end user, India microfluidics market is categorized into hospitals, industrial R&D, research laboratories and academia. Among them, the hospital segment is anticipated to witness fastest growth during the forecast period due to growing adoption of microfluidic techniques in hospitals for rapid diagnosis of various chronic diseases. Also, microfluidics provides closer monitoring and faster diagnosis, which is leading to high demand from hospital segment.
Major players operating in the India microfluidics market include Parker-Hannifin Corporation, SMS Corporation, Becton Dickinson Pvt Ltd, Roche Diagnostics India Private Limited, Bio-Rad laboratories India Pvt.Ltd, Murata Manufacturing Co Ltd, Danaher Corporation, Thermo Fisher Scientific Inc, Perkin Elmer Inc and Abbott Laboratories. The companies are focusing on developing new products through extensive R&D activities.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4933
Customers can also request for 10% free customization on this report.
“The thriving healthcare sector in India is providing huge growth opportunities for microfluidics companies. The country is witnessing increasing prevalence of chronic diseases and with this, the government is increasing investment on healthcare, thereby making India a lucrative market for microfluidics manufacturers. With demand for high-quality research tools for data reproducibility, the market is expected to undergo a rapid growth in the coming years,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.
“India Microfluidics Market By Component Type (Microfluidic Chips, Microfluidic Sensors, Microfluidic Pumps, Microneedles, Others), By Material (Polymer, Glass, Silicon, PDMS, Other), By Application (In Vitro diagnostics (Point-of-Care Testing, Clinical Diagnostics, Environmental Testing, Industrial Testing, Agro Food Testing), Pharmaceutical Research (Lab Analytics, Microdispensing, Microreaction), Drug Delivery (Inhaler Nozzles, Microneedles, Micropumps), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of India microfluidics market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in India microfluidics market.
Browse Related Reports
Global Self-monitoring Blood Glucose Market By Type (Type 1, Type 2, Hyperglycemia ,Hypoglycemia), By Frequency (One, Four, Others), By Product (Glucometer, Software, Test Strips, Lancet), By End-User (Hospital, Personal Care), By Region, Forecast & Opportunities, 2025
Global Portable Ventilator Market, By Type (Invasive Ventilation, Non-Invasive Ventilation), By Mode (Pressure Mode Ventilation; Volume Mode Ventilation; Combined Mode Ventilation), By Application (Aeromedical; Pediatrics; Domiciliary Ventilation; Non-Invasive Ventilation), By End User (Hospital; Ambulance; Clinic; Rehabilitation Center; Others), By Region, Forecast & Opportunities, 2025
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Friday 26 June 2020
India Dexamethasone Market to Witness Significant Growth During Forecast Period – TechSci Research
Increasing number of cases and deaths caused due to COVID-19 is expected to drive the growth of India dexamethasone market
According to TechSci Research report, “India Dexamethasone Market By Type (Injectables, Capsules, Tablets, Solutions), By Route of Administration (Oral v/s Intravenous), By Application (Asthma, Rheumatoid Arthritis, Skin Disorders, Covid-19, Ulcerative Colitis, Lupus, Allergic Disorders, Psoriasis, Others), By End Users (Hospitals, Clinics, Pharmacy, Others), By Region, Forecast & Opportunities, FY2026”, the India dexamethasone market is expected to grow at an impressive rate during the forecast period on account of the use for treating various diseases such as arthritis, skin conditions, eye care, respiratory & breathing problems, among others. Additionally, dexamethasone is a corticosteroid hormone which decreases body’s own defensive response and reduces symptoms such as swelling, allergic reactions, among others. This is an off-patent drug which is sold as a generic drug and also under the brand name DexPak, which is cost effective and manufactured by various big and small pharmaceutical companies in the country. Furthermore, the use of drug in high risk patients of COVID-19 is further expected to spur the market growth. However, side effects such as irritability, insomnia, muscle weakness, fluid retention, mood swings, increased appetite, increased blood sugar level, among others might hamper the market growth through FY2026. Also, cytokine over storm while fighting the deadly coronavirus might further restrict the market growth over the next few years.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on " India Dexamethasone Market"
The India dexamethasone market is segmented based on type, route of administration, application, end users, company and region. Based on type, the market can be categorized into injectables, capsules, tablets, and solutions. Here, the tablets segment is expected to dominate the market since they are safe, inexpensive, and safest form of oral medication. Additionally, they have a long shelf life, durable, chewable and can be split. Also, they can accommodate high dose of active ingredient. On the other hand, the capsule segment is expected to witness significant growth in the market since these are tasteless, tamper resistant and break down faster and easily. Further, they have a higher bioavailability and make a large amount of drug enter the bloodstream. Based on route of administration, the market can be split into oral and intravenous. Among these, the oral route is expected to dominate the market on account of its ease, safety, self-administration, prolonged absorption, among others. Additionally, the ease of digestion, efficient patient compliance and ability to accommodate various types of drugs further drive the segmental growth.
Cadila Healthcare Ltd., Wockhardt Ltd., Dwarkesh Pharmaceuticals Private Limited, Schwitz Biotech, Lexine Technochem Private Limited, Mapro Lifescience, Therawin Formulations, Shervotec Pharmaceuticals, Acichem Laboratories, Quality Nexgen Pharmaceuticals Pvt Ltd and others are some of the leading players operating in India dexamethasone market.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4935
Customers can also request for 10% free customization on this report.
“India dexamethasone market is expected to grow at a formidable rate during the forecast period on account of the emergence of the drug as a potential option to treat chronic COVID-19 patients and increasing the survival rate. India has a large number of pharmaceutical companies that are producing the drug at a very affordable rate. However, an increase in the price of API is expected by the drug manufacturers since more than 75% of the API are exported from China but due to the current border tensions with China and also halt in trading activities might lead to an increase in the manufacturing costs during the forecast period. Moreover, the drug has brought a ray of hope to the world for preventing deaths due to COVID-19 and if it gets the approval from FDA it will create lucrative opportunities for the market growth. Also, it will be quite beneficial for Indian pharmaceutical industry since India is one among the major producers of the drug.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“India Dexamethasone Market By Type (Injectables, Capsules, Tablets, Solutions), By Route of Administration (Oral v/s Intravenous), By Application (Asthma, Rheumatoid Arthritis, Skin Disorders, Covid-19, Ulcerative Colitis, Lupus, Allergic Disorders, Psoriasis, Others), By End Users (Hospitals, Clinics, Pharmacy, Others), By Region, Forecast & Opportunities, FY2026”,has evaluated the future growth potential of India dexamethasone market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in India dexamethasone market.
Browse Related Reports
Global Hydroxychloroquine and Chloroquine Market By Type (Injectables & Tablets), By Route of Administration (Oral v/s Intravenous), By Strength (100mg, 250mg & 500mg), By Application (Rheumatoid Arthritis, Malaria, COVID-19, Others), By Region, Competition, Forecast & Opportunities, 2030
Asia Pacific Favipiravir Market By Route of Administration (Oral v/s Intravenous), By Dosage Form (Tablet v/s Capsule), By Distribution Channel (Hospitals, Clinics, Drug Stores/Pharmacies, Online, Others), By Application (Influenza A&B, Ebola, COVID-19), By Country, Forecast & Opportunities, 2025
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-165
Email: sales@techsciresearch.com
Thursday 25 June 2020
Microfluidics Market to Witness Robust Growth through 2025 – TechSci Research
Rising demand for point-of-care testing and technological advancements in healthcare sector to drive global microfluidics market
According to TechSci Research report, “Global Microfluidics Market By Component Type (Microfluidic Chips, Microfluidic Sensors, Microfluidic Pumps, Microneedles, Others), By Material (Polymer, Glass, Silicon, PDMS, Other), By Application (In Vitro diagnostics (Point-of-Care Testing, Clinical Diagnostics, Environmental Testing, Industrial Testing, Agro Food Testing), Pharmaceutical Research (Lab Analytics, Microdispensing, Microreaction), Drug Delivery (Inhaler Nozzles, Microneedles, Micropumps), By Region, Forecast & Opportunities, 2025”, the market is expected to witness robust growth during the forecast period. Major factors contributing to the growth of global microfluidics market are growing demand for high-throughput screening methodologies and for point-of-care testing. Moreover, technological advancements coupled with development of advanced lab-on-a-chip technologies are accelerating the market growth. The market is also witnessing high demand for In Vitro Diagnostics (IVD) and high-throughput screening methodologies, which is acting as a major driver for global microfluidics market.
Additionally, rising focus on data precision & accuracy is one of the key factors for market growth. Advantages of microfluidics such as high return on investment and cost control by minimizing errors is creating their high demand in global market. Furthermore, microfluidics is finding wide application in medical sector for tissue engineering, pathogen detection in human/animals and point-of-care analysis. However, global microfluidics market might also face some challenges. Lack of market visibility of microfluidics products are restricting the market growth. Also, high price of integrated systems and microfluidics sensors and stringent government regulations related to approval of advanced microfluidics might hamper the growth of microfluidics market.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on "Global Microfluidics Market"
The global microfluidics market is segmented based on component type, material, application, sector, end user and region. Based on component type, the market is segmented into microfluidic chips, microfluidic sensors, microfluidic pumps, microneedles and others. Among them, microfluidic chips are expected to undergo fastest growth during the forecast period owing to increasing usage of microfluidic chips in microfluidic-based laboratory analytical instruments and increasing drug discovery & life science research. Furthermore, growing preference for personalized medicine and need for high-speed diagnostics are accelerating the demand for microfluidic chips in global market.
Based on application, global microfluidics market is categorized into in vitro diagnostics, pharmaceutical research and drug delivery. The in vitro diagnostics segment is further categorized into point-of-care testing, clinical diagnostics, environmental testing, industrial testing and agro food testing. Also, the pharmaceutical research segment is categorized into lab analytics, microdispensing, microreaction and drug delivery segment is categorized into inhaler nozzles, microneedles & micropumps. Among them, the in vitro diagnostics segment is expected to witness highest CAGR through 2025 owing to rising incidence of target diseases and growing need for point-of-care testing. Moreover, the advantages of point-of-care diagnostics over central lab testing methods are creating high demand for this segment.
Major players operating in the global microfluidics market include Abbott Laboratories, Inc., Perkinelmer, Inc., Cepheid, Inc., Sphere Fluidics Limited, FluIdigm Corporation, RainDance Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Johnson & Johnson Inc., Microfluidic Chipshop GMBH, Illumina Inc. and Dolomite Microfluidics (Blacktrace Holdings Ltd). The companies are focusing on developing new and improved products through extensive R&D activities.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4934
Customers can also request for 10% free customization on this report.
“North America accounted for largest market share in global microfluidics market in 2019 as the region possess high-quality infrastructure for clinical and laboratory research. Governments in countries such as United States and Canada are also investing on clinical trials and R&D activities, which is providing huge growth opportunities for companies dealing in microfluidics. North America is followed by Europe and Asia-Pacific, which are witnessing increasing incidence of chronic diseases,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Microfluidics Market By Component Type (Microfluidic Chips, Microfluidic Sensors, Microfluidic Pumps, Microneedles, Others), By Material (Polymer, Glass, Silicon, PDMS, Other), By Application (In Vitro diagnostics (Point-of-Care Testing, Clinical Diagnostics, Environmental Testing, Industrial Testing, Agro Food Testing), Pharmaceutical Research (Lab Analytics, Microdispensing, Microreaction), Drug Delivery (Inhaler Nozzles, Microneedles, Micropumps), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global microfluidics market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global microfluidics market.
Browse Related Reports
Global Self-monitoring Blood Glucose Market By Type (Type 1, Type 2, Hyperglycemia ,Hypoglycemia), By Frequency (One, Four, Others), By Product (Glucometer, Software, Test Strips, Lancet), By End-User (Hospital, Personal Care), By Region, Forecast & Opportunities, 2025
Global Portable Ventilator Market, By Type (Invasive Ventilation, Non-Invasive Ventilation), By Mode (Pressure Mode Ventilation; Volume Mode Ventilation; Combined Mode Ventilation), By Application (Aeromedical; Pediatrics; Domiciliary Ventilation; Non-Invasive Ventilation), By End User (Hospital; Ambulance; Clinic; Rehabilitation Center; Others), By Region, Forecast & Opportunities, 2025
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Wednesday 24 June 2020
Bioprocess Validation Market to Witness Significant Growth in the Coming Years - TechSci Research
High demand for outsourcing
of bioprocess validation services and increasing R&D spending in life
science industry to drive global bioprocess validation market
According
to TechSci Research report, “Global
Bioprocess
Validation Market By Test Type (Bacterial Retention, Extractables &
Leachables, Integrity Testing, Compatibility Testing, Microbiology Testing,
Patent Safety Evaluation), By Process Component (Bioreactors, Filter Elements,
Freezing and Thawing Process Bags, Media Containers and Bags, Mixing Systems,
Transfer Systems), By End User (Contract Development & Manufacturing
Organizations (CDMO), Biotechnology, Pharmaceutical Companies), By Region,
Forecast & Opportunities, 2025”, the market is expected to undergo robust growth during the
forecast period. The market is majorly driven by presence of stringent safety
and quality regulations governing product certification and testing across
pharmaceutical and biopharmaceutical industries to maintain agreement with Good
Manufacturing Practices (GMP). Moreover, advancements in the field of
pharmaceutical manufacturing and growing requirement to reduce production cost
across pharmaceutical and food companies are acting as major growth factors for
global bioprocess validation market. Further, high demand for outsourcing of
bioprocess validation services and increasing R&D spending in life science
industry are expected to fuel the market growth through 2025.
Additionally, growing use of use of sophisticated
facilities in the pharmaceutical industry is acting as one of the key factors
for bioprocess validation market growth. Also, increasing demand for bioprocess
validation in emerging countries and patent expiries are propelling the market
growth. Further, launch of new drugs in the pharmaceutical sector are expected
to boost the growth of global bioprocess validation market in the coming years.
However, the market is also facing some challenges. Issues associated with extractable
and leachable testing are acting as restraining factor for bioprocess
validation market growth.
Browse
XX market data Tables and XX Figures spread through XXX
Pages and an in-depth TOC on
"Global Bioprocess Validation Market"
The global
bioprocess validation market is segmented based on test type, process component,
end user and region. Based on test type, the market is segmented into bacterial
retention, extractables & leachables, integrity testing, compatibility
testing, microbiology testing and patent safety evaluation. Among them, the extractables
& leachables segment is anticipated to witness high demand during the
forecast period owing to presence of regulatory directives and guidelines
regarding the testing of extractables & leachables and increasing risk of
product adulterations. Moreover, growing concern related to product safety,
purity, identity and quality are also creating the demand for extractables
& leachables testing.
Based
on process component, global bioprocess validation market is segmented into bioreactors,
filter elements, freezing and thawing process bags, media containers and bags,
mixing systems and transfer systems. Among them, filter elements segment is
expected to undergo fastest growth through 2025 owing to the increasing usage
of a variety of filters in bioprocessing. Filter elements ensure the safety and
efficacy of biopharmaceutical products, which is creating their high demand in
global market.
Major players operating in the global bioprocess
validation market include Sartorius Stedim Biotech S.A., Pall Corporation,
Eurofins Scientific, SGS S.A., Cobetter Filtration Equipment Co., Ltd., Merck
KGaA, Thermo Fisher Scientific Inc., Toxikon Corporation, Meissner Filtration
Products, Inc., Doc S.R.L., Hangzhou Anow Microfiltration Co., Ltd., Almac
Group, Tianshan Precision Filter Material Co., Ltd. and Porvair plc. The
companies are investing a major portion of their sales revenue in R&D
activities. They are also focusing on launching superior quality products.
Customers
can also request for 10% free customization on this report.
“Asia
Pacific is anticipated to serve as a lucrative market for bioprocess validation
companies. The reasons can be attributed to growing biopharmaceutical
manufacturing capabilities and growing demand for outsourcing bioprocess
validation in Asian countries. The region is also witnessing an increase in awareness
about the advantages of biopharmaceutical drugs, especially in developing
nations like India and China. Apart from that, favorable government initiatives
in various APAC countries to promote the growth of pharmaceutical &
biotechnology industries is supporting the bioprocess validation market growth,”
said Mr. Karan Chechi, Research Director with TechSci Research, a research
based global management consulting firm.
“Global Bioprocess Validation Market By Test Type
(Bacterial Retention, Extractables & Leachables, Integrity Testing,
Compatibility Testing, Microbiology Testing, Patent Safety Evaluation), By Process
Component (Bioreactors, Filter Elements, Freezing and Thawing Process Bags,
Media Containers and Bags, Mixing Systems, Transfer Systems), By End User
(Contract Development & Manufacturing Organizations (CDMO), Biotechnology,
Pharmaceutical Companies), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global bioprocess
validation market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in global bioprocess validation
market.
Browse Related Reports
Global Self-monitoring Blood
Glucose Market By Type (Type 1, Type 2, Hyperglycemia ,Hypoglycemia), By
Frequency (One, Four, Others), By Product (Glucometer, Software, Test Strips,
Lancet), By End-User (Hospital, Personal Care), By Region, Forecast &
Opportunities, 2025
Global
Portable Ventilator Market, By Type (Invasive Ventilation, Non-Invasive
Ventilation), By Mode (Pressure Mode Ventilation; Volume Mode Ventilation;
Combined Mode Ventilation), By Application (Aeromedical; Pediatrics;
Domiciliary Ventilation; Non-Invasive Ventilation), By End User (Hospital;
Ambulance; Clinic; Rehabilitation Center; Others), By Region, Forecast &
Opportunities, 2025
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Subscribe to:
Posts (Atom)